Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. Futures Edge Lower on J&J Shock; Crucial Inflation Data Looms

Published 04/13/2021, 06:58 AM
Updated 04/13/2021, 06:59 AM
© Reuters.

By Peter Nurse   

Investing.com - U.S. stocks are seen opening marginally lower Tuesday, with negative news on the Covid-19 front weighing ahead of a highly anticipated inflation report which could guide near term market sentiment.

At 7:05 AM ET (1205 GMT), the Dow Futures contract was down 55 points, or 0.2%, S&P 500 Futures traded largely flat, and Nasdaq 100 Futures dropped 50 points, or 0.4%. All three contracts slid lower after the New York Times reported that U.S. authorities are set to call for a pause on distributing Johnson & Johnson's (NYSE:JNJ) vaccine, amid worries about blood clotting issues. A similar problem has plagued AstraZeneca (NASDAQ:AZN)'s drug.

This cautious trading comes ahead of the release of the March reading for the consumer price index, due at 8:30 AM ET (1330 GMT), which is expected to rise by 0.5% month-over-month and 2.5% year-over-year. 

Stock markets have climbed to record levels of late, helped by expectations of a strong U.S. economic recovery. But concerns are increasing that the combination of unprecedented levels of fiscal stimulus and pent up demand will lead to rampant inflation, forcing the Federal Reserve to tighten its monetary policies more quickly than earlier anticipated.

Fed officials have been at pains to point out that they see any bump up in inflation as temporary and remain committed to supporting the economic recovery until the jobs picture looks better, but a hefty CPI jump would raise the pressure, especially after Friday’s sharp rise in producer prices.

“With commodity prices and import prices continuing to surge and ISM manufacturing and services prices paid both at their highest level since 2008 there are increasing pipeline price pressures,” said analysts at ING, in a note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The bond market also traded in a subdued fashion Tuesday after a successful 10-year Treasury auction, with the benchmark yield edging slightly higher to trade near 1.69%, still well below the one-year high of around 1.78% seen at the end of March. 

Corporate news is set to pick up later in the week, with banking giants JPMorgan Chase (NYSE:JPM), Goldman Sachs (NYSE:GS) and Wells Fargo (NYSE:WFC) set to report quarterly results on Wednesday.

Ahead of this, Grab is likely to be in focus after the Asian ride-hailing and food delivery firm announced its intention to merge with Altimeter leading to a U.S. public listing, valuing the company at nearly $40 billion, the largest ever SPAC deal.

Oil prices edged higher Tuesday, helped by robust Chinese trade data, indicating continued economic recovery in the world’s largest crude importer, and tensions in the Middle East after the Yemen-based Houthi movement said it fired missiles on Saudi oil sites.

Attention Tuesday will also be on U.S. crude oil supply data from the American Petroleum Institute, while the Organization of Petroleum Exporting Countries is set to release its monthly report on the oil market.

U.S. crude futures traded 0.5% higher at $59.95 a barrel, while the Brent contract rose 0.5% to $63.61. 

Elsewhere, gold futures fell 0.2% to $1,729.45/oz, while EUR/USD traded 0.2% lower at 1.1891.

 

Latest comments

Perhaps blood clots are from the person giving the shot. The person giving our shots looked confused the whole time and was rereading a paper during the procedure.
dont worry.. market maker JPOW sitting on the bid
nursing a semi...
WHO is looking for vaccines. Problem solved.
Another vaccine causing blood clotting... are people waking up yet?
no, they die and dead people don't wake up I believe
no, they die and dead people don't wake up I believe .
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.